|
Digital Cognitive Behavioral Therapy for Chinese Adolescents With Depressive Symptoms(CADS-D )
RECRUITINGN/ASponsored by First Affiliated Hospital of Chongqing Medical University
Actively Recruiting
PhaseN/A
SponsorFirst Affiliated Hospital of Chongqing Medical University
Started2025-05-12
Est. completion2026-06-30
Eligibility
Age12 Years – 18 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07163013
Summary
CADS-D aimes to evaluate the effectiveness and feasibility of a newly DCBT program for Chinese adolescents with depressive symptoms.
Eligibility
Age: 12 Years – 18 YearsHealthy volunteers accepted
Inclusion Criteria: 1. Age 12 to 18 years; 2. Scored 28 or higher on the children's depression rating scale-revised (CDRS-R); 3. Have the ability to read and write in Chinese; 4. Participant and at least one of their guardians provided written consent; 5. Have access to mobile phone and internet. Exclusion Criteria: 1. The researchers assessed that the adolescent's depressive symptoms were too severe to participate to CADS-D; 2. Scored 5 or higher on item 13 (suicidal ideation) on CDRS-R; 3. Participants who met diagnosis of other mental disorder except depression; 4. Severe physical illnesses or other physical disabilities that prevented the use of DCBT; 5. Within the past three months or currently undergoing any antidepressant treatment, including medication therapy, psychotherapy, and physical therapy; 6. Unavailability to follow up months after intervention.
Conditions2
DepressionDepressive Symptom
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorFirst Affiliated Hospital of Chongqing Medical University
Started2025-05-12
Est. completion2026-06-30
Eligibility
Age12 Years – 18 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07163013